Cellerys AG

Cellerys AG focuses on relapsing remitting multiple sclerosis, with clinical activity centered on the treatment of autoimmune demyelinating disease affecting the central nervous system. The sponsor’s research interest is directed toward patients living with recurrent inflammatory disease activity and neurological impairment.

• Relapsing remitting multiple sclerosis
• Autoimmune central nervous system disease
• Inflammatory demyelination

The clinical program reflects a concentrated therapeutic interest in neurology and neuroimmunology, with attention to disease control in a chronic relapsing condition.